"Meritus Medical Center is an acute care hospital located in Hagerstown, Maryland with 247 beds, along with the most advanced technologies available. Services include a special care nursery, a level III trauma program, a primary stroke center, and a wound center, as well as a cardiac diagnostic laboratory. Other hospital services that address outpatient needs are the John R. Marsh Cancer Center, Total Rehab Care, the Center for Clinical Research, and the Center for Bariatric Surgery. State-of-the-art medical technologies at Meritus Medical Center include advanced 3T magnetic resonance imaging (MRI), single-photo-emission computed tomography (SPECT) scanners, and cardiac interventions."

During the past decade, Meritus Medical Center conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 11 clinical trials were completed, i.e. on average, 220% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Meritus Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 5 trials, followed by "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "Celgene" with 3 trials sponsored, "Bausch Health Americas, Inc." with 2 trials sponsored and "Brigham and Women's Hospital" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Meritus Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator, "Sanofi" with 2 trials as a collaborator, "American Cancer Society, Inc." with 1 trials as a collaborator, "American Society of Clinical Oncology" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Meritus Medical Center" are "Breast Cancer" (2 trials), "Deep Vein Thrombosis" (2 trials), "Eosinophilic Esophagitis" (2 trials), "Pulmonary Embolism" (2 trials) and "Recurrent Breast Carcinoma" (2 trials). Many other conditions were trialed in "Meritus Medical Center" in a lesser frequency.

Most popular intervention types in "Meritus Medical Center" are "Drug" (16 trials), "Other" (12 trials), "Biological" (5 trials), "Behavioral" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (4 trials), "Bevacizumab" (3 trials), "placebo" (3 trials), "CC-93538" (2 trials) and "Docetaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Meritus Medical Center" are 20 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Meritus Medical Center". undefined are not yet recruiting, 2 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Meritus Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Meritus Medical Center, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".

Meritus Medical Center has several departments that took part in Clinical trials: "Meritus Center For Clinical Research" - 33 trials, "John R. Marsh Cancer Center at Washington County Hospital" - 3 trials, "The John R Marsh Cancer Center" - 3 trials